BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Appoints Board Chair as New CEO
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announce the appointment of a new CEO: J. Melville (“Mel”) Engle. Engle is currently serving as chairman of the board and will continue to serve in that role as well as in his new position as CEO. Engle has more than two decades of impressive experience in the biotech and health-care industries. In his various roles as president, CEO, director, chairman of the board, CFO, senior vice president and more, he has gained invaluable expertise and insight into driving sales, unveiling…